Kangfan Ji
YOU?
Author Swipe
View article: An ultra-long acting insulin enables glucose-synchronised release
An ultra-long acting insulin enables glucose-synchronised release Open
Delayed and weak glucose-responsive kinetics, coupled with short plasma exposure and complicated formulation, remain major obstacles to the clinical translation of glucose-responsive insulin formulations. Here we report a rapidly absorbabl…
View article: Microneedle Patch for In Situ Neutrophil Monitoring
Microneedle Patch for In Situ Neutrophil Monitoring Open
Monitoring neutrophil levels plays an essential role in diagnosing infections and various diseases, as well as for managing specific treatments such as chemotherapy and radiotherapy. However, the traditional complete blood count technique …
View article: Macrophage-targeted <i>Mms6</i> mRNA-lipid nanoparticles promote locomotor functional recovery after traumatic spinal cord injury in mice
Macrophage-targeted <i>Mms6</i> mRNA-lipid nanoparticles promote locomotor functional recovery after traumatic spinal cord injury in mice Open
Traumatic spinal cord injury (SCI) causes severe central nervous system damage. M2 macrophages within the lesion are crucial for SCI recovery. Our previous research revealed that M2 macrophages transfected with magnetotactic bacteria–deriv…
View article: Mussel Foot Protein Membrane‐Enclosed Crystalline Drug with Zero‐Order Release Kinetics for Long‐Acting Therapy
Mussel Foot Protein Membrane‐Enclosed Crystalline Drug with Zero‐Order Release Kinetics for Long‐Acting Therapy Open
Injectable formulations with sustained and steady release capabilities are critically required to treat diseases requiring temporary or lifelong continuous therapy, especially for drugs with a short half‐life. Additionally, achieving a suf…
View article: Mussel Foot Protein Membrane‐Enclosed Crystalline Drug with Zero‐Order Release Kinetics for Long‐Acting Therapy
Mussel Foot Protein Membrane‐Enclosed Crystalline Drug with Zero‐Order Release Kinetics for Long‐Acting Therapy Open
Injectable formulations with sustained and steady release capabilities are critically required to treat diseases requiring temporary or lifelong continuous therapy, especially for drugs with a short half‐life. Additionally, achieving a suf…
View article: Tumor-specific liquid metal nitric oxide nanogenerator for enhanced breast cancer therapy
Tumor-specific liquid metal nitric oxide nanogenerator for enhanced breast cancer therapy Open
Nitric oxide (NO) modulates several cancer-related physiological processes and has advanced the development of green methods for cancer treatment and integrated platforms for combination or synergistic therapies. Although a nanoengineering…
View article: An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs
An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs Open
View article: Frontispiz: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment
Frontispiz: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment Open
View article: Frontispiece: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment
Frontispiece: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment Open
View article: Biomimetic design strategies for biomedical applications
Biomimetic design strategies for biomedical applications Open
View article: Week-long normoglycaemia in diabetic mice and minipigs via a subcutaneous dose of a glucose-responsive insulin complex
Week-long normoglycaemia in diabetic mice and minipigs via a subcutaneous dose of a glucose-responsive insulin complex Open
View article: Week-long normoglycaemia in diabetic mice and minipigs via a subcutaneous dose of a glucose-responsive insulin complex
Week-long normoglycaemia in diabetic mice and minipigs via a subcutaneous dose of a glucose-responsive insulin complex Open
View article: Material design for oral insulin delivery
Material design for oral insulin delivery Open